Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients

Rheumatology International

Volumn 25, Issue 5, 2005, Pages 326-331

  Tunc, S Ercan ^a,f   Aksu, Kenan ^b   Keser, Gokhan ^b   Oksel, Fahrettin ^b   Doganavsargil, Eker ^b   Pirildar, Timur ^c   Turk, Tufan ^d   Terzioglu, Ender ^e   Huseyinov, Afig ^b  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c CELAL BAYAR UNIVERSITY   (Turkey)

^d PAMUKKALE UNIVERSITY   (Turkey)

^e AKDENIZ UNIVERSITY   (Turkey)

^f NONE   (Turkey)

Author keywords

Beh et's disease; P selectin; Platelet activating factor; Thrombosis

Indexed keywords

PADGEM PROTEIN; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE ACTIVITY; ENDOTHELIUM INJURY; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; VEIN THROMBOSIS;

ADULT; BEHCET SYNDROME; CALCIMYCIN; CELLS, CULTURED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IONOPHORES; LEUKOCYTES; MALE; P-SELECTIN; PLATELET ACTIVATING FACTOR; VENOUS THROMBOSIS;

EID: 21544461524     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0450-4     Document Type: Article

References (30)

1. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet's disease. N Engl J Med 341:1284-1291
2. Yazici H, Yurdakul S, Hamuryudan V (1999) Behçet's syndrome. Curr Opin Rheum 11:53-57
3. Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz S et al (1992) Vascular involvement in Behçet's disease. J Rheumatol 19:402-410
4. Gül A (2001) Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 19 [Suppl 24]:S6-S12
5. Braquet P, Shen TY, Touqui L, Vargaftig B (1987) Perspectives in platelet activating factor research. Phamacol Rev 39:97-145
6. Zimmerman GA, McIntyre TM, Prescott SM (1995) Production of platelet-activating factor by human vascular endothelial cells: evidence of a requirement for specific agonists and modulation by prostacyclin. Circulation 72:718-727
7. 2+-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 80:134-142
8. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
9. Salari H (1986) Solid-phase extraction and reversed-phase high performance liquid chromatographic technique for isolation and estimation of platelet activating factor in plasma. J Chromatogr 382:89-98
10. Shattil SJ, Cunningham M, Hoxie JA (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70:307-315
11. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ (1990) Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 75:128-138
12. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM (2002) The platelet-activating factor system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 3 [Suppl 5]:S294-S301
13. Lorant DE, Zimmerman GA, McIntyre TM, Prescott SM (1995) Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. Semin Cell Biol 6:295-303
14. Lehr HA, Weyrich AS, Saetzier RK et al (1997) Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest 99:2358-2364
15. Elstat MR, La Pinc TR, Cowley FS, McEver RP, McIntyre TM, Prescott SM, Zimmerman GA (1995) P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes. J Immunol 155:2109-2122
16. Tetta C, Bussolino F, Modena V et al (1990) Release of platelet activating factor in systemic lupus erythematosus. Int Arch Allergy Appl Immunol 91:244-256
17. Warren JS, Mandel DM, Johnson KJ, Ward PA (1989) Evidence for the role of platelet activating factor in immune complex vasculitis in the rat. J Clin Invest 83:669-678
18. Haznedaroǧlu S, Karaaslan Y, Büyükasik Y, Kosar A, Özcebe Oİ, Haznedaroǧlu IC, Kirazli Ş, Dündar SV (2000) Selectin adhesion molecules in Behçet's disease. Ann Rheum Dis 59:61-63
19. Demopoulos CA, Andrikopoulos NK, Antonopoulou S (1994) A simple and precise method for the routine determination of platelet-activating factor in blood and urine. Lipids 29:305-309
20. Shinozaki K, Kawasaki T, Kambayashi J, Sakon M, Shiba E, Uemura Y, Ou M, Iwamoto N, Mori T (1994) A new method of purification and sensitive bioassay of platelet-activating-factor (PAF) in human whole blood. Life Sci 54:429-439
21. Imaizumi T (1991) Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking. Lipids 26:1269-1273
22. Imaizumi T, Satoh K, Yoshida H, Kawamura Y, Hiramoto M, Koyanagi M, Takamatsu S, Takamatsu M (1990) Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Heart Vessels 5:81-86
23. Miyaura S, Eguchi H, Johnston JM (1992) Effect of a cigarette smoke extract on the metabolism of the proinflammatory autocoid, platelet-activating factor. Circ Res 70:341-347
24. Sturm MJ, Strophair JM, Kendrew PJ, Vandongen R, Beilin LJ, Taylor RR (1989) Whole blood aggregation and plasma lyso-PAF related to smoking and atherosclerosis. Clin Exp Pharmacol Physiol 16:597-605
25. Bithell TC (1993) The physiology of primary hemostasis. In: Lee GR, Bithell TC, Foerster J, Atkens JW, Lukens JN (eds) Wintrobe's clinical hematology, 9th edn. Lea and Febiger, Philadelphia, pp 549-550
26. Hayashi J, Hiromura K, Koizumi R, Shimizu Y, Maezawa A, Nojima Y, Naruse T (2001) Platelet-activating factor antagonist, SM-12502, attenuates experimental glomerular thrombosis in rats. Nephron 87:274-278
27. Downing LJ, Wakefield TW, Strieter RM et al (1997) Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 25:816-827
28. Myers DD Jr, Henke PK, Wrobleski SK et al (2002) P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. J Vasc Surg 36:928-938
29. Yamada Y, Yoshida H, Ichihara S, Imaizumi T, Satoh K, Yakota M (2000) Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population. Atherosclerosis 150:209-216
30. Taylor RR, Sturm M, Kendrew PJ, Vandongen R, Beilin LJ (1989) Plasma levels of the lyso-derivative of platelet-activating factor are related to age. Clin Sci (Colch) 76:195-198